Clinical Trials in Detroit

Showing 16961-16980 of 19,719 trials

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

NCT01839045

The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins in your blood samples. The biomarker results along with your personal medical profile will be evaluated to determine your risk for the presence of a malignancy in the breast as compared to your breast evaluation assessment conducted by your physician.

Breast Cancer

Provista Diagnostics, Inc350 participantsStarted Mar 2013

Phoenix, Arizona, United States • Sacramento, California, United States • San Diego, California, United States +5 more locations

TERMINATEDPhase 2< 1 mile

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

NCT00267007

The purpose of this study is to evaluate the neuroprotective effect of PROCRIT (epoetin alfa, a glycoprotein that stimulates red blood cell production) versus placebo in patients with cancer who develop chemotherapy-induced peripheral neuropathy due to combination Taxane and Platinum-Based treatment.

Peripheral Neuropathy, Chemotherapy-induced

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.32 participantsStarted Jun 2006

Mobile, Alabama, United States • Little Rock, Arkansas, United States • Alhambra, California, United States +25 more locations

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Find Trials by Condition in Detroit

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

A Study Comparing Fusion Rates of Two Lumbar Fusion Procedures

A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy

12 / 48 Week Pivotal PFT vs PBO in COPD I

Safety of Urate Elevation in Parkinson's Disease

Pramipexole ER vs. Placebo in Fibromyalgia

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

Patient Registry Study of Berinert® in Normal Clinical Practice

Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease